Press Release Ceruvia Strengthens Intellectual Property Position for BOL-148 with Three U.S. Patent Allowances and Unitary Patent Grant in Europe 4 hours ago
Press Release Ceruvia Raises $8 Million to Complete Integrated Phase 1/2 Trial of Proprietary Non-Hallucinogenic LSD Analog for Cluster Headache Aug 3